Raynaud's phenomenon and hand function in patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 37, Issue 6, 2010, Pages 1358-1359

  Tansey, Rosamond J ^a   Wragg, Elizabeth A ^b   Herrick, Ariane L ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CONTROLLED STUDY; DISEASE DURATION; DURUOZ HAND INDEX; FEMALE; GRIP STRENGTH; HAND FUNCTION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; RAYNAUD PHENOMENON; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; FEMALE; HAND; HAND STRENGTH; HUMANS; HYPOKINESIA; MIDDLE AGED; MUSCLE RIGIDITY; PILOT PROJECTS; RAYNAUD DISEASE; TREMOR; YOUNG ADULT;

EID: 77953204476     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.091006     Document Type: Letter

References (10)

1. Carroll GJ, Withers K, Bayliss CE. The prevalence of Raynaud's syndrome in rheumatoid arthritis. Ann Rheum Dis 1981;40:567-570 (Pubitemid 12223266)
2. Saraux A, Allain J, Guedes C, Baron D, Youinou P, Le Goff P. Raynaud's phenomenon in rheumatoid arthritis. Br J Rheumatol 1996;35:752-754
3. Palmer KT, Griffin MJ, Syddall H, Pannett B, Cooper C, Coggan D. Prevalence of Raynaud's phenomenon in Great Britain and its relation to hand transmitted vibration: a national postal survey. Occup Environ Med 2000;57:448-452
4. Silman A, Holligan S, Brennan, Maddison P. Prevalence of symptoms of Raynaud's phenomenon in a general practice. Br Med J 1990;301:590-592 (Pubitemid 20346538)
5. McEntegart A, Capell HA, Creran D, Rumley A, Woodward M, Lowe GDO. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology 2001;40:640-644 (Pubitemid 32621801)
6. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Gonzales-Gay MA. Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumour necrosis factor α antibody. Arthritis Rheum 2004;51:447-450
7. Herrick AL. Pathogenesis of Raynaud's phenomenon. Rheumatology 2005;44:587-596
8. Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, et al. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis Rheum 2002;46:2410-2420
9. Duruoz MT, Poiraudeau S, Fermanian J, Menkes CJ, Arnor B, Dougados M, et al. Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol 1996;23:1167-1172 (Pubitemid 26240580)
10. Brower LM, Poole JL. Reliability and validity of the Duruöz Hand Index in persons with systemic sclerosis (scleroderma). Arthritis Rheum 2004;51:805-809